886 results on '"Eliasson, Björn"'
Search Results
2. Autoimmune comorbidity in type 1 diabetes and its association with metabolic control and mortality risk in young people: a population-based study
3. Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus
4. Physical activity trajectories and all-cause mortality in type 1 diabetes: A nationwide longitudinal study
5. Use of DPP4 Inhibitors and GLP-1 Receptor Agonists and Risk of Intestinal Obstruction: Scandinavian Cohort Study
6. Non-coronary peripheral arterial complications in people with type 2 diabetes: a Swedish retrospective cohort study
7. Non-coronary arterial outcomes in people with type 1 diabetes mellitus: a Swedish retrospective cohort study
8. Diabetes-related risk factors and survival among individuals with type 2 diabetes and breast, lung, colorectal, or prostate cancer
9. Risk factors for and risk of all-cause and atherosclerotic cardiovascular disease mortality in people with type 2 diabetes and peripheral artery disease: an observational, register-based cohort study
10. Identifying top ten predictors of type 2 diabetes through machine learning analysis of UK Biobank data
11. Registry-based randomised clinical trials: a remedy for evidence-based diabetes care?
12. The impact of a structured weight-loss treatment on physical fitness in patients with psoriatic arthritis and obesity compared to matched controls: a prospective interventional study
13. Twenty Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study
14. Testing and Visualization of Associations in Three-Way Contingency Tables: A Study on Gender Gap in Patients with Type I Diabetes and Cardiovascular Complications
15. The significance of chronic kidney disease, heart failure and cardiovascular disease for mortality in type 1 diabetes: nationwide observational study
16. Risk trajectories of complications in over one thousand newly diagnosed individuals with type 2 diabetes
17. HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target
18. Long-Term Cost Effectiveness of Oral Semaglutide Versus Empagliflozin and Sitagliptin for the Treatment of Type 2 Diabetes in the Swedish Setting
19. Locus of control and self-efficacy in relation to 12-month weight change after non-surgical weight loss treatment in adults with severe obesity – A clinical cohort study
20. Current and future costs of obesity in Sweden
21. Population median imputation was noninferior to complex approaches for imputing missing values in cardiovascular prediction models in clinical practice
22. Testing and Visualization of Associations in Three-Way Contingency Tables: A Study of the Gender Gap in Patients with Type 1 Diabetes and Cardiovascular Complications.
23. Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study.
24. Lifetime and 10‐year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE‐T1D model.
25. Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study
26. Development of a life expectancy table for individuals with type 1 diabetes
27. Comparison between data-driven clusters and models based on clinical features to predict outcomes in type 2 diabetes: nationwide observational study
28. Impact of Socioeconomic Factors and Gender on Refill Adherence and Persistence to Lipid-Lowering Therapy in Type 1 Diabetes
29. A registry-based randomised trial comparing an SGLT2 inhibitor and metformin as standard treatment of early stage type 2 diabetes (SMARTEST): Rationale, design and protocol
30. Effects of medical and surgical treatment on vitamin D levels in obesity
31. Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A scandinavian cohort study
32. Risk of fracture in adults with type 2 diabetes in Sweden: A national cohort study
33. Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial
34. The impact of diabetes mellitus on major amputation among patients with chronic limb threatening ischemia undergoing elective endovascular therapy- a nationwide propensity score adjusted analysis
35. Organisation of primary diabetes care in people with type 2 diabetes in relation to all-cause mortality: A nationwide register-based cohort study
36. Trends in Survival After First Myocardial Infarction in People With Diabetes.
37. Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study.
38. Cardiorenal and other diabetes related outcomes with SGLT-2 inhibitors compared to GLP-1 receptor agonists in type 2 diabetes: nationwide observational study
39. Reduced expression of OXPHOS and DNA damage genes is linked to protection from microvascular complications in long-term type 1 diabetes: the PROLONG study
40. Estimated glucose disposal rate and risk of stroke and mortality in type 2 diabetes: a nationwide cohort study
41. Variability in body weight and the risk of cardiovascular complications in type 2 diabetes: results from the Swedish National Diabetes Register
42. The BAriatic surgery SUbstitution and nutrition (BASUN) population: a data-driven exploration of predictors for obesity
43. Identification of markers that distinguish adipose tissue and glucose and insulin metabolism using a multi-modal machine learning approach
44. Early and long-term prognosis in patients with and without type 2 diabetes after carotid intervention: a Swedish nationwide propensity score matched cohort study
45. Nationwide comparison of long-term survival and cardiovascular morbidity after acute aortic aneurysm repair in patients with and without type 2 diabetes
46. Diabetes-Related Risk Factors and Survival among individuals with Type 2 Diabetes and Breast, Lung, Colorectal, or Prostate Cancer
47. Use of DPP4 Inhibitors and GLP-1 Receptor Agonists and Risk of Intestinal Obstruction: Scandinavian Cohort Study
48. Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure : Scandinavian register based cohort study
49. Risk Factors for Severe Liver Disease in Patients With Type 2 Diabetes
50. Persistence with IDegLira in Patients in Clinical Practice: A Nationwide Observational Study in Sweden
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.